BATS BZX Real-Time Price
As of 3:10pm ET
| -0.34 / -0.35%|
The 21 analysts offering 12-month price forecasts for AbbVie have a median target of 96.00, with a high estimate of 135.00 and a low estimate of 60.00. The median estimate represents a -0.14% decrease from the last price of 96.13.
The current consensus among 24 polled investment analysts is to Hold stock in AbbVie. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.